During the past decade, Macula and Retina Institute conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Macula and Retina Institute" #1 collaborator was "National Eye Institute (NEI)" with 3 trials as a collaborator, "National Institutes of Health (NIH)" with 3 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 2 trials as a collaborator, "CBCC Global Research" with 1 trials as a collaborator and "Kowa Company, Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Macula and Retina Institute" are "Diabetic Macular Edema" (2 trials), "Diabetic Retinopathy" (2 trials), "Epiretinal Membrane" (1 trials), "Geographic Atrophy" (1 trials) and "Macular Edema" (1 trials). Many other conditions were trialed in "Macula and Retina Institute" in a lesser frequency.

Most popular intervention types in "Macula and Retina Institute" are "Drug" (7 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "2-mg Intravitreous Aflibercept Injection" (1 trials), "Bevacizumab + Deferred Aflibercept Group" (1 trials), "Deferred Vitrectomy" (1 trials) and "Fenofibrate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Macula and Retina Institute" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Macula and Retina Institute". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Macula and Retina Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Macula and Retina Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".